Daniyar was diagnosed with beta-thalassemia major at eight months old. Since then, his life ran on a three-week cycle: hospital, transfusion, recovery, repeat. His parents had one dream — a cure — but no matched donor existed in the family or the registries.
The MedBridge team explained the “Beijing Protocol”: a haploidentical transplant using his mother as the donor, with outcomes comparable to matched-sibling transplants for children. The family arrived with two suitcases and a folder of transfusion records going back seven years.
Conditioning was the hardest week. The clean-ward nurses turned Daniyar’s isolation room into a space station, complete with a “mission log” on the wall. His mother donated stem cells on a Tuesday; by day +21, the new marrow was producing its own blood.
Discharge came with a detailed bilingual plan: medication tapering, infection precautions, and scheduled video reviews with the transplant team for the following year.
Outcome
Full donor chimerism, transfusion-independent since day +24. Daniyar now plays football with his older brother in Almaty.
“For eight years we counted days between transfusions. Now we count football goals. — Daniyar’s father”
All stories are anonymized composites based on real treatment journeys, shared with family consent. Names are pseudonyms and identifying details have been changed.
